Daniel F I Kurtycz, Zubair W Baloch, Ronald Balassanian, Terrance Lynn, Poonam Vohra, Maoxin Wu
{"title":"病理学家进行超声引导细针抽吸(US-FNA):美国细胞病理学协会赞助调查的现状、趋势和见解。","authors":"Daniel F I Kurtycz, Zubair W Baloch, Ronald Balassanian, Terrance Lynn, Poonam Vohra, Maoxin Wu","doi":"10.1016/j.jasc.2025.05.001","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Ultrasound-guided fine-needle aspiration (US-FNA) performed by cytopathologists represents prospects for expanding cytopathology practice. While there is a perceived need for further education and standardization to support future opportunities, this need remains insufficiently documented. The Product Innovation Committee of the American Society of Cytopathology conducted a survey to gather opinions and examine current practices in US-FNA.</p><p><strong>Materials and methods: </strong>An online survey of 32 questions focused on US-FNA practice was open from December 19, 2022, to March 19, 2023, promoted through national and international cytopathology professional societies, using Qualtrics survey software.</p><p><strong>Results: </strong>A total of 216 individuals accessed the survey, with 174 (68% from the USA) successfully completing a qualifying question. Data collected included information on certification, work setting, workload, and years of practice (mean: 16 years, range: 0-50 years). Fifty-nine percent (80/135) were certified in cytopathology by the American Board of Pathology or the International Academy of Cytology. Sixty-three percent (84/134) practiced in academia. Over one-half (70/123) worked in low-volume settings (0-50 US-FNA procedures/year), while 19% worked in medium-to-high volume settings (>300 US-FNA procedures/year). Responses showed variability in diagnostic practices and patient management. Nearly one-half (67/137) of respondents indicated that their pathologists performed US-FNA. Most, but not all, reported following standard procedures, including informed consent, site verification, procedure time-out, and documentation of both the procedure and ultrasound findings.</p><p><strong>Conclusions: </strong>Pathologist performed US-FNA represents an opportunity for growth, but there are significant barriers to adoption including: training, equipment, reimbursement, and procedural variability. This survey stands as an initial step to developing recommendations on best practices.</p>","PeriodicalId":38262,"journal":{"name":"Journal of the American Society of Cytopathology","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2025-05-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Pathologist performed ultrasound guided fine needle aspiration (US-FNA): current status, trends, and insights from the American Society of Cytopathology Sponsored Survey.\",\"authors\":\"Daniel F I Kurtycz, Zubair W Baloch, Ronald Balassanian, Terrance Lynn, Poonam Vohra, Maoxin Wu\",\"doi\":\"10.1016/j.jasc.2025.05.001\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Introduction: </strong>Ultrasound-guided fine-needle aspiration (US-FNA) performed by cytopathologists represents prospects for expanding cytopathology practice. While there is a perceived need for further education and standardization to support future opportunities, this need remains insufficiently documented. The Product Innovation Committee of the American Society of Cytopathology conducted a survey to gather opinions and examine current practices in US-FNA.</p><p><strong>Materials and methods: </strong>An online survey of 32 questions focused on US-FNA practice was open from December 19, 2022, to March 19, 2023, promoted through national and international cytopathology professional societies, using Qualtrics survey software.</p><p><strong>Results: </strong>A total of 216 individuals accessed the survey, with 174 (68% from the USA) successfully completing a qualifying question. Data collected included information on certification, work setting, workload, and years of practice (mean: 16 years, range: 0-50 years). Fifty-nine percent (80/135) were certified in cytopathology by the American Board of Pathology or the International Academy of Cytology. Sixty-three percent (84/134) practiced in academia. Over one-half (70/123) worked in low-volume settings (0-50 US-FNA procedures/year), while 19% worked in medium-to-high volume settings (>300 US-FNA procedures/year). Responses showed variability in diagnostic practices and patient management. Nearly one-half (67/137) of respondents indicated that their pathologists performed US-FNA. Most, but not all, reported following standard procedures, including informed consent, site verification, procedure time-out, and documentation of both the procedure and ultrasound findings.</p><p><strong>Conclusions: </strong>Pathologist performed US-FNA represents an opportunity for growth, but there are significant barriers to adoption including: training, equipment, reimbursement, and procedural variability. This survey stands as an initial step to developing recommendations on best practices.</p>\",\"PeriodicalId\":38262,\"journal\":{\"name\":\"Journal of the American Society of Cytopathology\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2025-05-13\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of the American Society of Cytopathology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1016/j.jasc.2025.05.001\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of the American Society of Cytopathology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/j.jasc.2025.05.001","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"Medicine","Score":null,"Total":0}
Pathologist performed ultrasound guided fine needle aspiration (US-FNA): current status, trends, and insights from the American Society of Cytopathology Sponsored Survey.
Introduction: Ultrasound-guided fine-needle aspiration (US-FNA) performed by cytopathologists represents prospects for expanding cytopathology practice. While there is a perceived need for further education and standardization to support future opportunities, this need remains insufficiently documented. The Product Innovation Committee of the American Society of Cytopathology conducted a survey to gather opinions and examine current practices in US-FNA.
Materials and methods: An online survey of 32 questions focused on US-FNA practice was open from December 19, 2022, to March 19, 2023, promoted through national and international cytopathology professional societies, using Qualtrics survey software.
Results: A total of 216 individuals accessed the survey, with 174 (68% from the USA) successfully completing a qualifying question. Data collected included information on certification, work setting, workload, and years of practice (mean: 16 years, range: 0-50 years). Fifty-nine percent (80/135) were certified in cytopathology by the American Board of Pathology or the International Academy of Cytology. Sixty-three percent (84/134) practiced in academia. Over one-half (70/123) worked in low-volume settings (0-50 US-FNA procedures/year), while 19% worked in medium-to-high volume settings (>300 US-FNA procedures/year). Responses showed variability in diagnostic practices and patient management. Nearly one-half (67/137) of respondents indicated that their pathologists performed US-FNA. Most, but not all, reported following standard procedures, including informed consent, site verification, procedure time-out, and documentation of both the procedure and ultrasound findings.
Conclusions: Pathologist performed US-FNA represents an opportunity for growth, but there are significant barriers to adoption including: training, equipment, reimbursement, and procedural variability. This survey stands as an initial step to developing recommendations on best practices.